Published in
Oxford University Press (OUP), Journal of the Pediatric Infectious Diseases Society, 6(10), p. 745-748, 2021
Links
Tools
Response to Trimethoprim-Sulfamethoxazole in a Pediatric Hematopoietic Stem Cell Transplant Recipient With Disseminated Toxoplasmosis: A Case Report
Journal article published in 2021 by
Aslam Khan 
,
Hayden T. Schwenk,
Krystal Kohlman,
Alice Bertaina ,
Stephanie Cho,
Jose G. Montoya,
Despina Contopoulos-Ioannidis
,
Hayden T. Schwenk,
Krystal Kohlman,
Alice Bertaina ,
Stephanie Cho,
Jose G. Montoya,
Despina Contopoulos-Ioannidis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Abstract We describe the presentation and treatment of a patient who developed ongoing fever and diagnosed with disseminated toxoplasmosis post-hematopoietic stem cell transplantation. He was initially treated with trimethoprim-sulfamethoxazole (TMP-SMX) and there was dramatic improvement in his fever curve. He successfully completed a modified course of therapy.